Wolverine Trading, LLC Cyclerion Therapeutics, Inc. Call Options Transaction History

Wolverine Trading, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 15, 2023	SELL	$0.43 - $0.9 $5,418 - $11,340	-12,600 Reduced 27.33%	33,500 $15,000
Q2 2022 Aug 15, 2022	SELL	$0.47 - $1.29 $2,585 - $7,095	-5,500 Reduced 10.66%	46,100 $25,000
Q1 2022 May 16, 2022	SELL	$0.96 - $1.78 $768 - $1,424	-800 Reduced 1.53%	51,600 $58,000
Q4 2021 Feb 14, 2022	BUY	$1.56 - $2.99 $54,444 - $104,351	34,900 Added 199.43%	52,400 $84,000
Q3 2021 Nov 12, 2021	BUY	$2.73 - $4.13 $47,775 - $72,275	17,500 New	17,500 $54,000

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $185M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.